Ad is loading...
GCLSX
Price
$27.44
Change
-$0.23 (-0.83%)
Updated
Nov 14 closing price
RMFCX
Price
$58.73
Change
-$0.40 (-0.68%)
Updated
Nov 14 closing price
Ad is loading...

GCLSX vs RMFCX

Header iconGCLSX vs RMFCX Comparison
Open Charts GCLSX vs RMFCXBanner chart's image
Goldman Sachs Large Cp Val Insghts Svc
Price$27.44
Change-$0.23 (-0.83%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$58.73
Change-$0.40 (-0.68%)
VolumeN/A
CapitalizationN/A
GCLSX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCLSX vs. RMFCX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCLSX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 106B vs. GCLSX (404M). RMFCX pays higher dividends than GCLSX: RMFCX (1.69) vs GCLSX (0.88). GCLSX was incepted earlier than RMFCX: GCLSX (26 years) vs RMFCX (22 years). GCLSX is a more actively managed with annual turnover of: 208.00 vs. RMFCX (25.00). GCLSX has a lower initial minimum investment than RMFCX: GCLSX (0) vs RMFCX (250). GCLSX annual gain was more profitable for investors over the last year : 27.45 vs. RMFCX (22.78). RMFCX return over 5 years is better than : 46.17 vs. GCLSX (31.45).
GCLSXRMFCXGCLSX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years22 years-
Gain YTD22.51017.440129%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets404M106B0%
Annual Yield % from dividends0.881.6952%
Returns for 1 year27.4522.78121%
Returns for 3 years2.5016.5415%
Returns for 5 years31.4546.1768%
Returns for 10 years75.7167.25113%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EML28.261.20
+4.43%
Eastern Company
MRNS0.310.01
+2.12%
Marinus Pharmaceuticals
SNAP10.76-0.35
-3.15%
Snap
AZTA42.62-1.88
-4.23%
Azenta
AUTL3.01-0.28
-8.51%
Autolus Therapeutics plc